Loading...

APC/Cyanine7 anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2_APCCyanine7_CD3_Antibody_031919_updated.png
C57BL/6 splenocytes were stained with CD45R/B220 FITC and CD3 (clone 17A2) APC/Cyanine7 (left) or Rat IgG2b, κ APC/Cyanine7 isotype control (right).
  • 17A2_APCCyanine7_CD3_Antibody_031919_updated.png
    C57BL/6 splenocytes were stained with CD45R/B220 FITC and CD3 (clone 17A2) APC/Cyanine7 (left) or Rat IgG2b, κ APC/Cyanine7 isotype control (right).
See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
100221 25 µg 84€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100222 100 µg 194€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is =0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Additional Product Notes

BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Teater M, et al. 2018. Nat Commun. 9:222. PubMed
  2. Revathikumar P, et al. 2018. PLoS One. 13:e0193210. PubMed
  3. Draijer C, et al. 2018. Sci Rep. 8:5105. PubMed
  4. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  5. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  6. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  7. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  8. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  9. Durgeau A, et al. 2018. Nat Commun. 9:5097. PubMed
  10. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  11. Adane B, et al. 2019. Cell Rep. 27:238. PubMed
  12. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  13. Haertel E, et al. 2018. Eur J Immunol. 48:1001. PubMed
  14. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  15. Rashidi M, et al. 2019. J Immunol. 203:736. PubMed
  16. Yin S et al. 2019. Cancer cell. 35(2):283-296 . PubMed
  17. Sanchez HN, et al. 2020. Nat Commun. 0.5. PubMed
  18. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  19. Rohner L, et al. 2020. Sci Rep. 0.570833333. PubMed
  20. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  21. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  22. Zhu W, et al. 2019. FASEB J. 33:5208. PubMed
  23. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  24. Shimizu K, et al. 2020. Molecular Cell. 77(5):937-950.e6.. PubMed
  25. Silver AC, et al. 2018. Heliyon. 4:e00579. PubMed
  26. Rafiq S, et al. 2018. Nat Biotechnol. 36:847. PubMed
  27. Jie Z, et al. 2014. J Immunol. 192:3289. PubMed
  28. Spees A, et al. 2014. Infect Immun . 82:1692. PubMed
  29. Mathews J, et al. 2014. PLoS One. 9:97707. PubMed
  30. Voss M, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L188 - L195. PubMed
  31. Wen J, et al. 2015. J Pharmacol Sci. 128: 116-124. PubMed
  32. Chung Y, et al. 2014. J Vis Exp. 89: 51660. PubMed
  33. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  34. Zhou Y, et al. 2016. Acta Pharmacol Sin. 10.1038/aps.2016.102. PubMed
  35. Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed
  36. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  37. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  38. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  39. Jandke A, et al. 2020. Nat Commun. 3.075694444. PubMed
  40. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  41. Bellomo A, et al. 2020. Immunity. 53(1):127-142.e7. PubMed
  42. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  43. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  44. Shi L, et al. 2021. Immunity. . PubMed
  45. Pandey V, et al. 2021. eLife. 0.416666666666667. PubMed
  46. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  47. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  48. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  49. Wang Z, et al. 2020. Autophagy. 1:. PubMed
  50. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  51. Israelow B, et al. 2020. bioRxiv. . PubMed
  52. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  53. Socodato R, et al. 2020. Sci Signal. 13: . PubMed
  54. Leimkühler NB, et al. 2020. Cell Stem Cell. 28:637. PubMed
  55. Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed
  56. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  57. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  58. Nakazawa S, et al. 2020. Sci Rep. 10:14559. PubMed
  59. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  60. Marques RM, et al. 2021. Cell Death Differ. 28:3140. PubMed
  61. Super M, et al. 2021. Nat Biomed Eng. Online ahead of print. PubMed
  62. Fischer FA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  63. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  64. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  65. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  66. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  67. Rouse MD, et al. 2020. Front Microbiol. 11:414. PubMed
  68. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  69. Robles-Oteiza C, et al. 2021. Dis Model Mech. 14:. PubMed
  70. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  71. Xue L, et al. 2021. BMC Cancer. 21:1134. PubMed
  72. Herman JD, et al. 2021. Nat Commun. 12:6853. PubMed
  73. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  74. Han JP, et al. 2022. Sci Adv. 8:eabj6901. PubMed
  75. Lang V, et al. 2021. Elife. 10:. PubMed
  76. Liu X, et al. 2022. Nat Cancer. :. PubMed
  77. Kim MY, et al. 2022. Nat Commun. 13:3296. PubMed
  78. Miyauchi E, et al. 2020. Nature. 585:102. PubMed
  79. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  80. Tirado-Gonzalez I, et al. 2021. Cancer Discov. 11:2924. PubMed
  81. Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
  82. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  83. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  84. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  85. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  86. Chen S, et al. 2022. Cancer Discov. :. PubMed
  87. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
  88. Katsinas N, et al. 2022. J Clin Med. 11:. PubMed
  89. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  90. Li C, et al. 2021. Chem Biol Drug Des. 97:1151. PubMed
  91. Chung H, et al. 2021. Immune Netw. 21:e28. PubMed
  92. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  93. Mackel JJ, et al. 2022. Front Cell Infect Microbiol. 12:974175. PubMed
  94. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  95. Diao L, et al. 2022. iScience. 25:105511. PubMed
  96. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  97. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  98. Zhou H, et al. 2022. EMBO Rep. 23:e53791. PubMed
  99. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  100. Lin G, et al. 2022. Int J Immunopathol Pharmacol. 36:3946320221117933. PubMed
  101. Lee SH, et al. 2023. Nutrients. 15: . PubMed
  102. Zhang B, et al. 2023. Signal Transduct Target Ther. 8:28. PubMed
  103. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  104. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  105. Abu Hejleh AP, et al. 2023. Int J Tryptophan Res. 16:11786469231153111. PubMed
  106. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  107. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  108. Tao X, et al. 2022. J Exp Med. 219:. PubMed
  109. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  110. Jeon Y, et al. 2022. Cancers (Basel). 14:. PubMed
  111. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  112. Swan SL, et al. 2023. Front Immunol. 14:1085547. PubMed
  113. Spitzer D, et al. 2023. Nat Protoc. 18:1510. PubMed
  114. Wang YC, et al. 2023. J Exp Med. 220:. PubMed
  115. Li G, et al. 2023. Cell Death Dis. 14:185. PubMed
  116. Cheng MI, et al. 2023. Nat Immunol. 24:780. PubMed
  117. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  118. Pelletier A, et al. 2023. EMBO Rep. 24:e56156. PubMed
  119. Tong L, et al. 2023. Sci Adv. 9:eade5041. PubMed
  120. Yazicioglu YF, et al. 2023. Nat Immunol. 24:991. PubMed
  121. Zhang J, et al. 2023. Theranostics. 13:2226. PubMed
  122. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  123. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
RRID
AB_2057374 (BioLegend Cat. No. 100221)
AB_2242784 (BioLegend Cat. No. 100222)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 03.19.2019

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account